Product Information

LAMOTRIGINE ER 25 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.2540 per EA under NDC 00228141003. Its NADAC has been published 537 times since May 11, 2016.

FDA first approved this application on Oct 17, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMOTRIGINE ER 25 MG TABLET

Lamotrigine
$0.2540per EA

Strength

25 mg/1

NDC

00228141003

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA200672

FDA Approved

10/17/2013

TE Code

AB

On Market Since

4/1/2016

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ER 25 MG TABLET has been published 537 times since May 11, 2016, and over the history we have for it it has declined 93.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2540 per EA
All-time high$3.6031 (May 11, 2016)
All-time low$0.2224 (Nov 20, 2024)
52-week high$0.5196
52-week low$0.2421
Median price$1.1909
Average price$1.4280
Largest weekly change+90.5% (Dec 18, 2024)
Weeks tracked537
Tracking sinceMay 11, 2016

Price History

1W

+4.9%

1M

+4.9%

3M

-29.8%

6M

-21.7%

1Y

-51.1%

3Y

-49.2%

5Y

-82.3%

All

-93.0%

Generic Alternatives

The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ER 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 25 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.2540 per EA (NDC 00228141003), effective Aug 19, 2026.

How has the price of LAMOTRIGINE ER 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ER 25 MG TABLET has declined 93.0%. It has been tracked across 537 weekly CMS publications since May 11, 2016.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 25 MG TABLET?

Since May 11, 2016, the NADAC for LAMOTRIGINE ER 25 MG TABLET has ranged from a low of $0.2224 (Nov 20, 2024) to a high of $3.6031 (May 11, 2016), with a median of $1.1909 per EA.

Are there cheaper alternatives to LAMOTRIGINE ER 25 MG TABLET?

Yes. 19 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG TABLET, is $0.0271 per EA — about 89% below LAMOTRIGINE ER 25 MG TABLET.

Who manufactures LAMOTRIGINE ER 25 MG TABLET?

LAMOTRIGINE ER 25 MG TABLET (NDC 00228141003) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.